PER percheron therapeutics limited

Ann: Trial Met Primary & Exceeded Secondary Endpoint Expectations, page-4

  1. 3,917 Posts.
    lightbulb Created with Sketch. 901
    Report is excellent as expected but wont do much justice to the SP....

    Long holders will hold...some impatient may move some funds...hence bit of sell off
    Hope I am wrong...

    Forward plans sound good. Next few months will be big for ANP...

    IMO
    Arjay
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.8¢
Change
-0.001(5.88%)
Mkt cap ! $8.699M
Open High Low Value Volume
0.8¢ 0.8¢ 0.8¢ $2.01K 251.2K

Buyers (Bids)

No. Vol. Price($)
9 4817091 0.8¢
 

Sellers (Offers)

Price($) Vol. No.
0.9¢ 1969872 4
View Market Depth
Last trade - 15.47pm 04/07/2025 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.